Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.

Matika RW, Nielsen VG, Steinbrenner EB, Sussman AN, Madhrira M. "Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide." ASAIO J.. 2014;60(6):716-21.